Brief: XSpray Pharma Q3 Loss Before Tax Widens To SEK 28.7 Mln

Xspray Pharma publ AB

09/11/2022 07:35

Nov 9 (Reuters) - XSpray Pharma AB (publ)  XSPRAY.ST :
    * INTERIM REPORT THIRD QUARTER 2022
    * Q3 NET SALES AMOUNTED TO SEK 0 THOUSAND (0)
    * Q3 LOSS BEFORE TAX AMOUNTED TO SEK -28,651 THOUSAND
(-13,890)

Source text for Eikon:  ID:nMFN8MgcK2 
Further company coverage:  XSPRAY.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))